Attached files

file filename
EX-31.02 - EXHIBIT 31.02 - Tonix Pharmaceuticals Holding Corp.s109195_ex31-02.htm
EX-31.01 - EXHIBIT 31.01 - Tonix Pharmaceuticals Holding Corp.s109195_ex31-01.htm
EX-23.1 - EXHIBIT 23.1 - Tonix Pharmaceuticals Holding Corp.s109195_ex23-01.htm
EX-21.01 - EXHIBIT 21.01 - Tonix Pharmaceuticals Holding Corp.s109195_ex21-01.htm
10-K - 10-K - Tonix Pharmaceuticals Holding Corp.s109195_10k.htm

Exhibit 32.01

 

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Seth Lederman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Tonix Pharmaceuticals Holding Corp. on Form 10-K for the fiscal year ended December 31, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Tonix Pharmaceuticals Holding Corp.

 

    By:  

/s/ SETH LEDERMAN

Date: March 9, 2018   Name:   Seth Lederman
    Title:   Chief Executive Officer

 

I, Bradley Saenger, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Tonix Pharmaceuticals Holding Corp. on Form 10-K for the fiscal year ended December 31, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Tonix Pharmaceuticals Holding Corp.

 

    By:  

/s/ BRADLEY SAENGER

Date: March 9, 2018   Name:   Bradley Saenger
    Title:   Chief Financial Officer